Life Insurance for Multiple Sclerosis
Life Insurance for Multiple Sclerosis
Jason Stolz CLTC, CRPC, DIA, CAA
Life insurance with multiple sclerosis (MS) is absolutely possible for many applicants — especially when the condition is stable, well-managed, and clearly documented. At Diversified Insurance Brokers, we specialize in helping individuals with MS find affordable coverage by matching your medical profile to carriers that are more open to neurological histories. Because we work with 100+ insurers nationwide, we can often avoid the one-size-fits-all approach that leads to overpricing, flat extras, or unnecessary declines. Multiple sclerosis is a condition that underwriters treat differently depending on the details. Two people can both have an MS diagnosis and receive completely different outcomes based on the type of MS, how long it has been since diagnosis, relapse history, mobility and daily functioning, medications, and whether the disease appears stable over time. The goal is to present a clean, accurate underwriting story that makes it easy for a carrier to classify your risk fairly — rather than assuming the worst-case scenario. This guide covers what drives life insurance approval and pricing for MS, what you should gather before applying, how to reduce underwriting friction so you get the most competitive offer available, and why the same MS profile can produce radically different outcomes depending on carrier selection and case presentation. MS is an autoimmune condition — and like other autoimmune conditions, the range of severity and the importance of carrier selection make strategy the most important variable in the application process. The prescreening approach that prevents avoidable declines is covered in detail in our resource on how to prescreen a life insurance application — the most important step before any formal MS application is submitted.
Life Insurance With Multiple Sclerosis
If you’re living with MS, you don’t have to assume you’re uninsurable or stuck with a “last resort” policy. We’ll position your diagnosis correctly and shop carriers that are more MS-friendly.
Get a Quote Today Call 800-533-5969Life Insurance Quoter
Use the quoter below as a starting reference for coverage amounts and term lengths. For MS cases specifically, the quoter gives you a baseline — the real work is identifying which carriers evaluate neurological histories most favorably for your specific disease course and stability profile.
See Real-Term Rates Side by Side
MS Types and Life Insurance Underwriting — Expected Outcomes by Disease Course
The table below maps the major MS disease courses to the underwriting approaches that typically apply. These are general reference points — individual carrier guidelines, specific relapse history, functional status documentation, and overall health picture all affect actual outcomes for any individual case.
General reference only. Actual underwriting outcomes depend on full medical history, specific carrier guidelines, documentation quality, and individual case presentation. Not a guarantee of any rate class or coverage.
| MS Profile | Disease Course | Typical Underwriting Approach | Likely Outcomes | Key Documentation Priority |
|---|---|---|---|---|
| RRMS — Stable, long remission (5+ years), no significant disability, consistent neurologist care | Relapsing-Remitting | Most favorable RRMS tier — long stability history makes risk more predictable; carrier selection determines how well this profile is priced | Standard to moderate table ratings achievable at MS-experienced carriers; some applicants closer to standard than expected when documentation is strong | Neurologist note explicitly confirming stability/remission; relapse date timeline; functional independence documentation; stable MRI pattern |
| RRMS — Active, relapse within 2 years, full recovery, maintained function | Relapsing-Remitting | Conservative but achievable — recent relapse creates more uncertainty; full recovery after relapse helps; carrier selection critical | Moderate to higher table ratings typical; term coverage most accessible; documentation of full recovery and maintained function key differentiator | Relapse date, duration, treatment used; neurologist notes documenting full recovery; current functional status; current MRI compared to prior imaging |
| RRMS — Frequent relapses, incomplete recovery, or significant functional limitations | Relapsing-Remitting | More restrictive — file complexity increases significantly; carriers concerned about progression trajectory | High table ratings or declinations at most carriers; simplified issue or guaranteed issue may be more realistic; specialty carrier market required | Complete relapse history with dates; EDSS score if available; current neurologist assessment; mobility aid documentation if applicable |
| SPMS — Early/mild progression, mild disability, continued function independence | Secondary Progressive | Significantly more conservative than RRMS — progressive disease carries different mortality assumptions; carrier selection essential | Higher table ratings common; some specialty carriers more favorable than others; term coverage most achievable; face amounts may be limited | Rate of progression documentation; current functional assessment; neurologist notes on disease trajectory; employment and daily activity status |
| SPMS or PPMS — Significant disability, mobility aids, functional limitations in ADLs | Secondary or Primary Progressive | Most restrictive — significant disability changes the mortality risk calculation substantially; most standard carriers will decline | Simplified issue or guaranteed issue most realistic; smaller face amounts; final expense coverage most accessible; fully underwritten unlikely | Mobility aid type and dependence level; ADL limitations documentation; current neurologist assessment; caregiver situation if applicable |
| Clinically Isolated Syndrome (CIS) or newly diagnosed MS — No prior relapses, strong function | Initial presentation / Very early MS | Variable — recent diagnosis creates uncertainty about future disease course; carrier selection critical; some carriers postpone until stability is demonstrated | Some carriers will consider coverage with table ratings if function is strong; others may postpone 12-24 months pending disease course clarification | Complete neurologist records from initial diagnosis through current; current MRI; functional status confirmation; treatment plan documentation |
How Multiple Sclerosis Affects Life Insurance Underwriting
When an insurance company underwrites an MS case, they are trying to answer a few practical questions: Is the disease stable? Has it progressed? What is the probability of increased disability over time? And how well is the applicant monitoring and treating the condition? Modern MS treatment and monitoring has improved dramatically over the last two decades, but underwriting guidelines vary widely by carrier. Some companies still price MS conservatively based on older actuarial assumptions that do not reflect the disease management improvements that contemporary disease-modifying therapies provide. Others are more up-to-date and will offer reasonable terms when the medical record supports stability. This is why the carrier you apply to matters as much as your diagnosis itself. In many cases, getting a fair offer is less about finding a loophole and more about selecting the right insurer and presenting the history clearly. For broader context on how neurological conditions are evaluated alongside other complex health histories, our resource on life insurance for Parkinson’s disease covers the parallel neurological underwriting framework — structurally similar to MS evaluation in several important respects.
MS Type Matters, But Stability Matters Even More
Underwriters generally view relapsing-remitting MS (RRMS) more favorably than progressive forms, but the bigger driver is how the condition behaves over time. If you have RRMS with long periods of stability, few or no recent relapses, and consistent neurologist follow-up, many carriers will consider traditional term life or permanent coverage. If the record suggests frequent relapses, rapid progression, or significant disability, underwriting becomes tougher and pricing increases. Even when a carrier can approve coverage, they may apply additional pricing — sometimes using a table rating, and in certain cases a separate extra charge per thousand dollars of coverage. If you have ever been quoted a surcharge, this is often what the industry refers to as a flat extra in life insurance. The best way to minimize that outcome is to apply to carriers that treat stable MS more reasonably and provide documentation that supports favorable classification.
What Underwriters Specifically Look For with MS — The Evaluation Framework
| Evaluation Factor | What Carriers Examine | What Strengthens the File | What Creates Underwriting Friction |
|---|---|---|---|
| Time Since Diagnosis and Symptom Timeline | How long since first symptom, diagnosis date, years of documented stability, pattern over time | Long periods with documented stability; several years since last meaningful relapse; clear timeline showing consistent specialist management throughout | Very recent diagnosis (less than 12-24 months) with limited stability history; unclear symptom onset timeline; gaps in medical care during the observation period |
| Relapse History and Recovery Pattern | Frequency and timing of relapses, severity of each episode, degree of recovery after each relapse, whether relapses are trending in frequency | Long gaps between relapses; full or near-full recovery documented after each episode; neurologist notes confirming remission; stable or improving relapse frequency pattern | Recent relapse (within 12 months); incomplete recovery documented after relapses; worsening relapse frequency trend; relapses requiring hospitalization or IV steroids |
| Functional Status and Mobility | Walking ability, use of mobility aids, employment status, independence in daily activities, EDSS score if documented | Full functional independence; no mobility aids; continued employment; neurologist notes confirming intact ADL independence; EDSS score in favorable range | Dependence on cane, walker, or wheelchair; limitations in activities of daily living; unemployment attributed to disability; significant cognitive or bladder/bowel dysfunction noted |
| Neurologist Follow-Up and Treatment Compliance | Regularity of specialist visits, consistency of disease-modifying therapy adherence, record completeness, care gaps | Regular neurologist visits documented; stable, long-term DMT regimen; no extended gaps in specialty care; specialist notes explicitly confirming stability | Irregular or infrequent specialist follow-up; multiple DMT changes suggesting treatment failure; significant care gaps; neurologist notes lacking specificity about disease status |
| MRI Findings and Objective Monitoring | Imaging trend over time, evidence of new lesion activity vs. stable lesion burden, specialist interpretation of imaging findings | MRI showing stable lesion burden with no new active lesions; specialist interpretation explicitly confirming imaging stability; regular imaging schedule maintained | New or enlarging lesions on recent MRI; significant lesion burden progression; gadolinium-enhancing lesions suggesting active inflammation; no recent imaging to confirm stability |
| Overall Health Profile Beyond MS | Blood pressure, cholesterol, diabetes, tobacco use, build, family history, other conditions — all evaluated alongside MS in the total risk picture | Non-tobacco status; controlled comorbidities; healthy build; no additional high-risk conditions; favorable family history; young to middle age with favorable age-based mortality | Tobacco use; uncontrolled comorbidities like diabetes or hypertension; significant overweight; additional chronic conditions that compound the MS risk picture |
MS and Women — The Demographic Most Affected
Multiple sclerosis affects women at approximately three times the rate of men, with most diagnoses occurring between ages 20 and 50. This demographic reality creates a life insurance context that differs significantly from many other high-risk conditions that tend to affect older populations. Young women with MS often have substantial financial responsibilities — young children, mortgages, income replacement needs, and partner income dependency — that make life insurance both meaningful and urgent. The favorable aspect of this demographic context is that a 35-year-old woman with well-managed RRMS has an overall mortality profile that differs significantly from an older applicant with the same diagnosis alongside other health complications. Age-based mortality assumptions favor younger applicants, and when RRMS is stable and clearly documented, the combination of favorable age profile plus stable disease can produce better underwriting outcomes than many MS patients expect based on prior experiences with conservative carriers. For younger MS patients who want to access coverage quickly through a simplified pathway — without the delay of a full paramed exam and records request — our resource on no-exam life insurance for young adults covers the accelerated underwriting programs that may be accessible for stable RRMS applicants in lower coverage amount tiers. The earlier MS coverage is secured — when the disease course is most favorable and the stability window is longest — the more favorable the pricing relative to waiting for additional years of disease progression history to accumulate.
MS Disease-Modifying Therapies and What They Signal to Underwriters
Disease-modifying therapies (DMTs) are a central feature of modern MS management and a significant underwriting data point. Underwriters use the DMT history as a proxy for both disease severity and treatment strategy — what is prescribed, at what line of therapy, and whether the regimen has been stable or frequently changed all shape the underwriting picture. The most basic antimicrobial and first-line DMTs — such as interferons and glatiramer acetate — are associated with mild to moderate RRMS and signal that first-line treatment has been adequate to control disease activity. When treatment escalates to high-efficacy DMTs such as natalizumab (Tysabri), ocrelizumab (Ocrevus), or alemtuzumab (Lemtrada), underwriters infer that the disease required more aggressive management — either due to treatment failure at lower lines, higher disease activity, or clinical or imaging evidence that initial therapy was insufficient. Escalation to high-efficacy agents does not automatically disqualify an applicant, but it does shift the underwriting picture toward more conservative assumptions and typically requires more detailed documentation of the reason for escalation and the current disease status on the new therapy. Frequent DMT changes — cycling through multiple agents in a short period — often signal treatment instability that underwriters interpret as evidence of poorly controlled disease. A long-term stable relationship with a single DMT, combined with favorable clinical and imaging outcomes, tells the most favorable possible story about MS management and is the documentation profile that produces the best underwriting outcomes.
Why Applying the Right Way Matters for MS
MS cases often go sideways for one of two reasons: the wrong carrier is selected, or the case is submitted with gaps that trigger conservative assumptions. Underwriters are trained to manage uncertainty, and when information is missing, they tend to price for worst-case outcomes. That is why the process matters. In many MS cases, friction can be reduced by pre-framing the file: getting the timeline right, explaining stability, clarifying relapse history, and making sure medication and follow-up care are easy to understand. When the file is clean, many carriers can move faster and price more fairly. Some policies require a full medical exam, while others can be streamlined. If you are wondering what a full underwriting process typically includes, our overview of what is a life insurance exam covers the mechanics. Understanding what activities of daily living are — and how functional independence is documented and evaluated — is equally important for MS applicants, because functional status is one of the central underwriting evaluation factors.
Many clients with complex health histories start by reviewing options for life insurance with pre-existing conditions so they understand how carriers view layered risk. The parallel evaluation framework for other neurological conditions — including our resource on life insurance for Parkinson’s — covers how progressive neurological disease is assessed, a framework with meaningful similarities to the progressive MS evaluation path. For context on how inflammatory and connective tissue conditions — which share some underwriting parallels with MS — are evaluated, our resource on life insurance for arthritis covers how mobility limitations and inflammatory history affect rate class outcomes. For context on what a standard policy does not cover — relevant for any applicant evaluating whether coverage exclusions might affect the value of a policy — our resource on what deaths are not covered by life insurance covers the standard exclusion framework.
What Helps You Get Better Rates With Multiple Sclerosis
There is no single magic factor that guarantees approval, but there are patterns that consistently appear in MS-friendly underwriting outcomes. The best offers tend to come when the record supports predictability and control. From an underwriting perspective, stability is the story. If you can demonstrate a long period with minimal or no relapses, consistent neurologist care, and stable function, you give the carrier a rational basis for a better rate class. This is especially true when neurologist notes explicitly describe the condition as stable or well-controlled. The value of explicit language in neurologist notes cannot be overstated — a note that says “patient has been neurologically stable with no new relapse activity” tells underwriting what it needs to classify the risk efficiently. A note that simply lists medications and a planned follow-up date leaves the classification decision entirely to underwriting assumption.
MS is only one component of underwriting. If you have strong overall health — good build, stable labs, no tobacco, controlled blood pressure — your MS case can be evaluated in a more favorable context. If you have other conditions, the approach matters: carriers view the total risk picture, not individual conditions in isolation. For MS applicants who are also managing cardiovascular risk — either as a comorbidity or as a condition with intersecting inflammatory mechanisms — our resource on life insurance after cardiac events covers how cardiovascular history is evaluated alongside neurological history in the combined risk assessment that applies to complex files. For MS applicants who want to understand how their annuity income or retirement planning can work alongside life insurance coverage decisions, our resource on how annuity payments can fund life insurance premiums covers how these tools integrate at the household financial planning level.
MS and Disability Insurance — The Coverage Dimension Life Insurance Doesn’t Address
Many people with MS are thinking about both mortality protection and income protection simultaneously — because MS creates significant disability risk in addition to mortality risk. Life insurance protects your family if you die, but it does not pay your bills if MS prevents you from working. For MS patients who remain employed, disability insurance is often the more financially urgent coverage need: the probability of a significant disability period during working years is substantially higher than early mortality for most RRMS patients in their 40s and 50s. Our resource on disability insurance covers the income protection dimension that MS patients should evaluate alongside life insurance. The earlier disability coverage is secured — while still actively employed and before disability claims history exists — the better the coverage terms and pricing typically are. MS applicants who already have disability claims history may find disability insurance coverage difficult to obtain at favorable terms, making the timing of disability insurance application particularly important for MS patients who are currently stable and employed.
Term Life vs. Permanent Life Insurance for MS
MS applicants often assume they should only apply for one type of policy, but the best structure depends on the purpose of coverage and how underwriting falls. In general, term insurance is the most cost-effective way to buy a larger death benefit for income replacement, mortgage protection, or family protection. Permanent insurance can make sense when you want lifelong coverage, estate planning, or a policy designed to stay in force regardless of age. For MS cases, underwriting can vary by product line within the same company — one carrier might be more flexible for term but more conservative for permanent. Another might prefer permanent designs. This is another reason shopping the market matters instead of taking one quote at face value. If you are comparing term coverage amounts, our term life insurance calculator can help frame the benefit level conversation before going through full underwriting. For MS applicants who later want to convert an approved term policy to permanent coverage — particularly as the disease course becomes clearer over time and the desire for lifetime coverage grows — our resource on converting term to permanent life insurance covers the conversion process and timing considerations.
Common Mistakes That Hurt MS Life Insurance Offers
Most MS applicants do not lose good offers because of their diagnosis alone. They lose them because the file becomes difficult to underwrite or raises concerns that could have been prevented with smarter preparation. Applying to a carrier that treats MS conservatively is the most common mistake — if the first carrier you try is restrictive with neurological conditions, you may get a higher-than-necessary rate class, a flat extra, or a decline even when other carriers would approve you. This is why shopping the market is a risk management strategy, not just a sales phrase. Submitting an unclear relapse timeline is another common problem — underwriting wants clarity on when symptoms started, when diagnosis occurred, the dates of relapses, and the level of recovery. If those details are vague, the carrier may assume the worst. Not separating MS limitations from unrelated health issues also creates friction — sometimes functional limitations are attributed to MS when they are actually due to orthopedic injuries, weight, or unrelated conditions, and when medical notes do not clearly separate causes, underwriting may treat the limitation as MS progression. For applicants over 50 with MS, the age-related cost increase intersects with the MS rating — understanding how these factors combine is covered in our resource on life insurance over 50.
If You’ve Been Declined for MS, You Still Have Options
A prior decline does not always mean you are uninsurable. In many cases, it means the carrier you applied to did not like the combination of factors in the file or could not get comfortable with the documentation. Other carriers may view the same case differently. When traditional underwriting is difficult, there may also be alternative policy designs with fewer medical requirements. For some MS applicants — especially when mobility impairment is advanced — families may also consider smaller final expense coverage as an additional layer. Our resource on burial insurance for people with multiple sclerosis covers that option in detail. For the guaranteed issue pathway — which requires no health questions and provides coverage regardless of MS severity — our resource on guaranteed issue burial insurance covers the graded benefit structure, face amount limitations, and when this option makes sense as either a primary or supplemental coverage solution. For MS applicants whose condition also creates long-term care planning questions — particularly around whether Medicare will cover future care needs — our resource on whether Medicare covers long-term care addresses that important planning question alongside the life insurance discussion.
MS and Related Conditions — Underwriting Parallels for Complex Files
MS does not always present in isolation. Some MS patients also have other autoimmune conditions, inflammatory diseases, or conditions with overlapping mechanisms that compound the underwriting picture. For files involving both MS and another significant condition, the carrier selection and documentation strategy becomes even more critical because each additional condition adds to the uncertainty that underwriters must price for. Our resource on life insurance for sarcoidosis covers another multisystem inflammatory condition with neurological involvement that shares several underwriting evaluation parallels with complex MS files. Understanding how these conditions are evaluated individually and in combination helps MS applicants with complex medical histories position their applications most effectively across the carrier market.
Get an MS-Friendly Market Comparison
If you’ve been overquoted or declined, we’ll shop carriers and present your MS history the right way — so you can see real options across the full market.
Request My MS Quote Review Call 800-533-5969Related Pages
Life insurance services, long-term care planning resources, and carrier reviews relevant to MS planning decisions.
Financial Protection Essentials
Life insurance resources for other neurological, autoimmune, and complex conditions that share underwriting parallels with multiple sclerosis.
Compare Term Life Insurance Lengths
Explore different term periods to find coverage that best matches your timeline and budget.
Talk With an Advisor Today
Choose how you’d like to connect—call or message us, then book a time that works for you.
Schedule here:
calendly.com/jason-dibcompanies/diversified-quotes
Licensed in all 50 states • Fiduciary, family-owned since 1980
FAQs: Life Insurance With Multiple Sclerosis
Can I get life insurance if I have multiple sclerosis?
Yes — many people with MS can qualify for traditional term or permanent life insurance, especially when the condition is stable and well-documented. The underwriting outcome depends primarily on the type of MS, how stable the disease course has been, relapse history, functional status, current medications, and the quality of specialist documentation. RRMS with a long remission history and no mobility limitations often produces the most favorable underwriting outcomes. Progressive MS with significant disability is more restrictive but still has options through simplified issue and guaranteed issue pathways. If you want a broader overview of options for complex medical histories, our resource on life insurance with pre-existing conditions covers how carriers approach chronic and neurological conditions generally.
Does the type of MS change underwriting outcomes?
Usually yes, but stability matters more than the label itself. Relapsing-remitting MS (RRMS) often underwrites more favorably than primary progressive (PPMS) or secondary progressive (SPMS) forms — because the relapsing-remitting course allows for meaningful stable periods that underwriters can evaluate as evidence of disease control. However, a poorly controlled RRMS case with frequent relapses and incomplete recovery can underwrite worse than a mild, stable SPMS case with documented slow progression and strong functional independence. The combination of MS type, stability history, functional status, specialist documentation, and overall health profile together determines the underwriting outcome — with stability and documentation often being the differentiating factors between a good offer and a poor one.
What medical records help the most with an MS application?
Neurologist notes are the most important document — specifically notes that explicitly describe the disease as stable, confirm remission status, document relapse dates and recovery, and provide an assessment of current functional status. A clear relapse timeline (dates, severity, treatment used, and degree of recovery) removes the ambiguity that triggers conservative underwriting assumptions. Current medication history showing a stable long-term disease-modifying therapy regimen signals management consistency. MRI summaries — particularly notes comparing current imaging to prior scans and confirming stable or improving lesion burden — provide the objective monitoring documentation that supports the stability narrative. If neurologist notes are vague or incomplete, underwriting fills the gaps with conservative assumptions rather than favorable ones.
Will I need a life insurance medical exam with MS?
It depends on the carrier, coverage amount, and the specific underwriting pathway selected. Some applications require a full paramed exam including blood draw, urine sample, and blood pressure measurement alongside attending physician statement and medical records. Others can be streamlined through accelerated underwriting programs for stable MS applicants requesting moderate coverage amounts. For stable RRMS applicants in favorable health otherwise, no-exam underwriting pathways may be accessible — our resource on no-exam life insurance covers those pathways. For cases requiring full underwriting, our overview of what a life insurance exam includes covers what to expect from the paramed process and how to prepare for the records request.
What does “flat extra” mean for MS cases?
A flat extra is an additional charge per thousand dollars of coverage — separate from your base rate — that some carriers apply when they view the risk as elevated but still insurable. For example, a $5 per thousand flat extra on a $500,000 policy adds $2,500 to the annual premium beyond the standard table-rated premium. Flat extras are sometimes applied for a defined temporary period (e.g., 5 years) or permanently, depending on how the carrier views the long-term disease trajectory. Our resource on what is a flat extra in life insurance covers how both table ratings and flat extras work, how to calculate the total cost of a rated offer, and when a flat-extra offer represents meaningful coverage at an acceptable cost relative to the alternative of no coverage.
What if I’m declined for traditional life insurance coverage?
A decline from one carrier does not automatically mean you are uninsurable. Different insurers treat MS very differently — a carrier that declines based on conservative neurological guidelines may be the wrong market entirely, while a carrier with more MS-specific underwriting experience may view the same file as approvable with a table rating. If traditional underwriting is genuinely unavailable at this time — perhaps due to recent relapse, progressive disease, or significant disability — simplified issue final expense coverage provides meaningful protection without medical exam requirements. Our resource on burial insurance for MS covers that option. The guaranteed issue pathway provides coverage regardless of health history, with a graded benefit period and limited face amounts — appropriate as a fallback when all other pathways are unavailable.
Does MS affect whether term or permanent life insurance is better?
Not universally, but it can influence what is priced most reasonably at any given carrier. Term insurance typically offers the most cost-effective coverage per dollar of death benefit for income replacement, mortgage payoff, and family protection needs — and for MS applicants who qualify for fully underwritten coverage, term is usually the starting point for larger face amounts. Permanent coverage — including guaranteed universal life or whole life — makes sense when the goal is lifetime protection, estate planning, or ensuring coverage stays in force regardless of any future health changes. One important consideration for MS applicants is converting a term policy to permanent coverage before the conversion window closes — because MS progression over time could make future insurability uncertain. Our resource on converting term to permanent covers the conversion process and the timing considerations that make early conversion planning particularly relevant for applicants with progressive neurological conditions.
Are life insurance death benefits taxable for MS policyholders?
In most situations, beneficiaries receive the life insurance death benefit income-tax free under IRC Section 101(a), regardless of how the policy was obtained or whether the insured had a pre-existing condition like MS. The tax-free nature of the death benefit is one of the most valuable financial features of life insurance — the full face amount passes to beneficiaries without income tax, unlike most retirement account distributions. There are exceptions in certain ownership or estate scenarios — particularly when the policy is owned by the estate, when a three-party ownership arrangement exists (owner, insured, and beneficiary are three different parties), or when the policy was transferred for value. Our resource on whether life insurance death benefits are taxable covers those exception scenarios in detail.
Why do some carriers treat MS so differently from others?
Each insurer has its own underwriting philosophy, internal claims experience database, and actuarial assumptions about MS mortality risk. Carriers that have significant historical experience underwriting MS cases — and have accumulated claims data showing actual outcomes for stable RRMS applicants — are often more comfortable with favorable terms for well-documented stable cases. Carriers without that specific experience base may apply conservative blanket guidelines for all neurological conditions regardless of individual presentation. Additionally, underwriting guidelines evolve as MS treatment and outcomes improve — carriers that have updated their guidelines to reflect modern disease-modifying therapy effectiveness will price stable MS cases more favorably than carriers still using older actuarial assumptions. This is precisely why market shopping across 100+ carriers produces meaningfully different results for MS applicants than limiting the comparison to a single company’s view.
How does MS affect disability insurance eligibility, and should I apply for both?
MS creates both mortality risk (addressed by life insurance) and income disruption risk (addressed by disability insurance), and both should be evaluated — ideally before any disability has occurred or been claimed. For MS patients who are currently employed and in a stable disease phase, individual disability insurance is most accessible and most favorably priced when applied for proactively rather than reactively. Once disability claims history exists, obtaining new disability coverage becomes significantly harder. The intersection of MS and disability insurance is covered in our resource on disability insurance — which addresses how MS history affects eligibility, what waiting periods apply, and how to structure income protection that complements life insurance rather than duplicating it. For MS patients managing the complete financial protection picture — life insurance for mortality risk, disability insurance for income disruption, and long-term care planning for eventual care needs — the earlier each coverage layer is evaluated and secured, the better the coverage terms typically are.
What happens to my MS life insurance coverage if my condition worsens?
Once a life insurance policy is issued and in force, the coverage terms are locked — the insurer cannot cancel the policy, raise the premium, or reduce the death benefit based on any future health changes, including MS progression, additional relapses, or new disability. This is one of the most important reasons to secure life insurance coverage while your MS is most stable and your documentation is most favorable: the policy you obtain today cannot be repriced or cancelled tomorrow based on how the disease evolves. This irrevocability of in-force coverage is also why the timing of application matters so much for MS patients — waiting until “things stabilize further” can be counterproductive if the stability window that exists today is actually the best underwriting opportunity available, and future progression narrows or eliminates that window. The death benefit and premium remain exactly as agreed at policy issuance for the full term or duration of the policy, regardless of MS disease course changes after coverage is secured.
Should I tell my life insurance company if my MS worsens after the policy is issued?
No — you are not required to disclose changes in health that occur after a life insurance policy is issued. The underwriting process occurs at the time of application, and the insurer’s obligation to pay the death benefit at claims time is based on accurate disclosure at application — not on your health status at any point after issuance. Once the policy is in force, it remains in force as long as premiums are paid, regardless of any health changes that occur. This is fundamentally different from health insurance, where current health status affects ongoing coverage terms. The disclosure obligation in life insurance runs in one direction only: accurate and complete disclosure at the time of application. Post-issuance health changes have no effect on the policy’s validity or the death benefit your beneficiaries will receive.
About the Author:
Jason Stolz, CLTC, CRPC, DIA, CAA and Chief Underwriter at Diversified Insurance Brokers (NPN 20471358), is a senior insurance and retirement professional with more than 25 years of real-world experience helping individuals, families, and business owners protect their income, assets, and long-term financial stability. As a long-time partner of the nationally licensed independent agency Diversified Insurance Brokers, Jason provides trusted guidance across multiple specialties—including fixed and indexed annuities, long-term care planning, personal and business disability insurance, life insurance solutions, Group Health, and short-term health coverage. Diversified Insurance Brokers maintains active contracts with over 100 highly rated insurance carriers, ensuring clients have access to a broad and competitive marketplace.
His practical, education-first approach has earned recognition in publications such as VoyageATL, highlighting his commitment to financial clarity and client-focused planning. Drawing on deep product knowledge and years of hands-on field experience, Jason helps clients evaluate carriers, compare strategies, and build retirement and protection plans that are both secure and cost-efficient. Visitors who want to explore current annuity rates and compare options across multiple insurers can also use this annuity quote and comparison tool.
Explore More Life Insurance Options: Browse our complete guide to High Risk Life Insurance — covering health conditions, guaranteed issue, special needs & underwriting challenges from 100+ carriers.
